This morning, GlaxoSmithKline announced a $3 billion criminal settlement with the Department of Justice to settle accusations that it didn't tell regulators about safety problems with an infamous ...

It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...

Assistant Editor, Hannah Blake, picks this series back up, starting here with the history of GlaxoSmithKline. GlaxoSmithKline (GSK) is a science-led global healthcare company, which headquarters ...

Pharmaceuticals giant GlaxoSmithKline has told thousands of staff to turn off the NHS Covid-19 app while at work. It told them to switch off the Bluetooth contact-tracing feature at its research ...

GlaxoSmithKline paid U.S. medics to prescribe potentially dangerous medicines to adults and children. It handed out cash as well as everything from Madonna concert tickets to pheasant-hunting trips.

GlaxoSmithKline (GSK) is to merge its consumer healthcare unit with that of rival Pfizer, to create a new market leader with almost £10bn in annual sales. The UK pharmaceutical firm - behind many ...

Pharmaceutical firm GlaxoSmithKline has said it wants to make it easier for manufacturers in the world's poorest countries to copy its medicines. The British company said it would not file patents ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Britain has historically respected the principal of double jeopardy in international investigations but the has not always been so amenable GlaxoSmithKline’s problems are multiplying fast.

In the Queen Elizabeth II conference centre opposite Westminster Abbey, shareholders of GlaxoSmithKline gathered to anoint Sir Philip Hampton as new chairman of the UK’s biggest drugmaker.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. When Hervé Gisserot was asked to ride to the rescue of GlaxoSmithKline’s crisis-hit Chinese operations ...

Pharmaceutical firm GlaxoSmithKline has said it wants to make it easier for manufacturers in the world's poorest countries to copy its medicines. The British company said it would not file patents ...